Lilly shares rise on hopes that next-gen drug will extend lead in weight-loss market
Eli Lilly shares rose 4% on Monday, driven by compelling new data for its next-generation obesity drug, retatrutide, with analysts and investors expecting it to extend the
June 08, 2026
Don't expect a repeat. UFC boss Dana White says 'never again' to another White House fight night
'It's tough': Father says son with two baby boys died in Missouri plane crash
Woman's $2 bet during work break leads to $572K Kentucky Lottery jackpot win
Iran prepares for World Cup debut after months of uncertainty
World Cup: South American teams start off on the wrong foot
US Trade Representative Greer to visit India on June 23-24 for talks
Canadian housing starts fall 6% in May